Document
IPR2024-00631, No. 1502 Exhibit - 1502 CV of Judith Korner, MD, PhD (P.T.A.B. Mar. 1, 2024)
Cite Document
IPR2024-00631, No. 1502 Exhibit - 1502 CV of Judith Korner, MD, PhD (P.T.A.B. Mar. 1, 2024)
+ More Snippets
Document
IPR2024-00631, No. 1077 Exhibit - 1077 Award ClinicalTrialsgov, httpsashharvardedunewsclinicaltrials (P.T.A.B. Mar. 1, 2024)
Cite Document
IPR2024-00631, No. 1077 Exhibit - 1077 Award ClinicalTrialsgov, httpsashharvardedunewsclinicaltrials (P.T.A.B. Mar. 1, 2024)
+ More Snippets
Document
IPR2024-00631, No. 1058 Exhibit - 1058 Blonde, Comparison of Liraglutide Versus Other Incretin Related Anti H (P.T.A.B. Mar. 1, 2024)
Cite Document
IPR2024-00631, No. 1058 Exhibit - 1058 Blonde, Comparison of Liraglutide Versus Other Incretin Related Anti H (P.T.A.B. Mar. 1, 2024)
+ More Snippets
Document
IPR2024-00631, No. 1067 Exhibit - 1067 US Patent No 8,536,122 (P.T.A.B. Mar. 1, 2024)
Cite Document
IPR2024-00631, No. 1067 Exhibit - 1067 US Patent No 8,536,122 (P.T.A.B. Mar. 1, 2024)
+ More Snippets
Document
IPR2024-00009, No. 2025 Exhibit - EX2025 Excerpt of Opening Expert Report of William J Jusko, PhD Regarding Invalidity of US Patent No 10,335,462, In re Ozempic Semaglutide Patent Litigation, No 22
Cite Document
IPR2024-00009, No. 2025 Exhibit - EX2025 Excerpt of Opening Expert Report of William J Jusko, PhD Regarding Invalidity of US Patent No 10,335,462, In re Ozempic Semaglutide Patent Litigation, No 22
+ More Snippets
Document
IPR2024-00009, No. 1007 Exhibit - Declaration of Paul Dalby, PhD (P.T.A.B. Oct. 20, 2023)
Cite Document
IPR2024-00009, No. 1007 Exhibit - Declaration of Paul Dalby, PhD (P.T.A.B. Oct. 20, 2023)
+ More Snippets
Document
IPR2024-00009, No. 1062 Exhibit - Zarin, The ClinicalTrialsgov Results Data, 364 NEW ENGL J MED 852 2011 (P.T.A.B. Oct. 20, 2023)
Cite Document
IPR2024-00009, No. 1062 Exhibit - Zarin, The ClinicalTrialsgov Results Data, 364 NEW ENGL J MED 852 2011 (P.T.A.B. Oct. 20, 2023)
+ More Snippets
Document
IPR2024-00009, No. 1096 Exhibit - CV of Dr Maureen M Donovan (P.T.A.B. Oct. 20, 2023)
Cite Document
IPR2024-00009, No. 1096 Exhibit - CV of Dr Maureen M Donovan (P.T.A.B. Oct. 20, 2023)
+ More Snippets
Document
IPR2024-00009, No. 1034 Exhibit - US Patent No 6,268,343 (P.T.A.B. Oct. 20, 2023)
Cite Document
IPR2024-00009, No. 1034 Exhibit - US Patent No 6,268,343 (P.T.A.B. Oct. 20, 2023)
+ More Snippets
Document
IPR2024-00009, No. 1023 Exhibit - Drucker, Enhancing Incretin Action 26 DIABETES CARE 2929 2003 (P.T.A.B. Oct. 20, 2023)
Cite Document
IPR2024-00009, No. 1023 Exhibit - Drucker, Enhancing Incretin Action 26 DIABETES CARE 2929 2003 (P.T.A.B. Oct. 20, 2023)
+ More Snippets
Document
IPR2024-00009, No. 1088 Exhibit - Markman Hearing Transpt Re OzempicNo 22 MD 3038 D Del July 13, 2023 (P.T.A.B. Oct. 20, 2023)
Cite Document
IPR2024-00009, No. 1088 Exhibit - Markman Hearing Transpt Re OzempicNo 22 MD 3038 D Del July 13, 2023 (P.T.A.B. Oct. 20, 2023)
+ More Snippets
Document
IPR2024-00009, No. 1047 Exhibit - Tamimi, Drug Development, 13 NEPHRON CLINICAL PRACTICE c125 2009 (P.T.A.B. Oct. 20, 2023)
Cite Document
IPR2024-00009, No. 1047 Exhibit - Tamimi, Drug Development, 13 NEPHRON CLINICAL PRACTICE c125 2009 (P.T.A.B. Oct. 20, 2023)
+ More Snippets
Document
IPR2024-00009, No. 1064 Exhibit - Monami, Effects of Glucagon Like Peptide 1 EXPER DIABETES RSCH 1 2012 (P.T.A.B. Oct. 20, 2023)
Cite Document
IPR2024-00009, No. 1064 Exhibit - Monami, Effects of Glucagon Like Peptide 1 EXPER DIABETES RSCH 1 2012 (P.T.A.B. Oct. 20, 2023)
+ More Snippets
Document
IPR2024-00009, No. 1039 Exhibit - Victoza, PHYSICIANS’ DESK REFERENCE 65th ed 2010 (P.T.A.B. Oct. 20, 2023)
Cite Document
IPR2024-00009, No. 1039 Exhibit - Victoza, PHYSICIANS’ DESK REFERENCE 65th ed 2010 (P.T.A.B. Oct. 20, 2023)
+ More Snippets
Document
IPR2024-00009, No. 3001 Exhibit - Exhibit 3001 (P.T.A.B. Feb. 13, 2024)
Cite Document
IPR2024-00009, No. 3001 Exhibit - Exhibit 3001 (P.T.A.B. Feb. 13, 2024)
+ More Snippets